Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials
Saturday, May 17, 2025IQVIA has entered into a strategic partnership with SCRI Development InnovationsThe collaboration aims to improve the way oncology trials are conducted worldwide benefiting biopharmaceutical companies and ultimately patients
WuXi Biologics and CANbridge Celebrate Approval of Innovative Therapy for Gaucher Disease in China
Saturday, May 17, 2025WuXi Biologics has announced the approval of velaglucerasebeta for injection Gaurunning developed in partnership with CANbridge Pharmaceuticals by Chinas National Medical Products Administration NMPA
Travere Therapeutics FILSPARI® sNDA Accepted by FDA for FSGS Treatment
Friday, May 16, 2025Travere Therapeutics Inc has announced that the US Food and Drug Administration FDA has accepted its supplemental New Drug Application sNDA for FILSPARI sparsentan for the treatment of focal segmental glomerulosclerosis FSGS
BrainChild Bio Receives FDA RMAT Designation for B7-H3 CAR T-cell Therapy Targeting Paediatric Brain Tumours
Friday, May 16, 2025BrainChild Bio has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for its investigational BH CAR Tcell therapy
Tempus Enters into Collaboration with Boehringer Ingelheim to Advance Cancer Treatment
Thursday, May 15, 2025Tempus AI has entered into a new multiyear collaboration with Boehringer IngelheimThe partnership aims to support the development of Boehringer Ingelheims cancer research pipeline building on previous work between the two companies
AbbVie’s EMRELIS™ Receives FDA Accelerated Approval for Advanced Non-Small Cell Lung Cancer With High c-Met Overexpression
Thursday, May 15, 2025AbbVie has announced that the US Food and Drug Administration FDA has granted accelerated approval for EMRELIS telisotuzumab vedotintllv to treat adults with locally advanced or metastatic nonsquamous nonsmall cell lung cancer NSCLC characterised by...
ABLi Therapeutics Launches with Novel Parkinson’s Therapy
Tuesday, May 13, 2025ABLi Therapeutics ABLi has officially launchedThe company is dedicated to developing therapies that target conditions caused by the activation of Abelson Tyrosine Kinases cAbl kinases with Parkinsons disease and related disorders as its primary focus
Beam Therapeutics Receives RMAT Designation from U.S. FDA for BEAM-302 in Treatment of AATD
Tuesday, May 13, 2025Beam Therapeutics has announced that the US Food and Drug Administration FDA has granted Regenerative Medicine Advanced Therapy RMAT designation to BEAM
InnoCare Receives Approval for Mesutoclax in R/R Mantle Cell Lymphoma
Tuesday, May 13, 2025InnoCare Pharma has announced that its Bcell lymphoma BCL inhibitor Mesutoclax ICP has received Breakthrough Therapy Designation BTD from the Center for Drug Evaluation CDE of the China National Medical Products Administration NMPA
Amneal and Apiject Expand BFS Capabilities to Strengthen U.S. Sterile Drug Manufacturing
Friday, May 09, 2025Amneal Pharmaceuticals and Apiject Systems have announced a strategic partnership to boost domestic pharmaceutical production in the United StatesThe collaboration will expand the use of Apijects BlowFillSeal BFS injectable platform at Amneals facili...
